Capricor Therapeutics Inc - ESG Rating & Company Profile powered by AI
This assessment of Capricor Therapeutics Inc was assembled by All Street Sevva using leading Cognitive Robots. The Disclosure rating includes seventeen UN SDGs including: 'Affordable & Clean Energy', 'Industry, Innovation & Infrastructure' and 'Life below Water'. This webpage is a zero-cost ESG analysis covering Capricor Therapeutics Inc.
Capricor Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.4; made up of an environmental score of 8.0, social score of 3.2 and governance score of 8.0.
6.4
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 389 | WuXi Biologics (Cayman) Inc | 6.6 | High |
| 401 | Oxford Cannabinoid Technologies Holdings PLC | 6.5 | High |
| 402 | Capricor Therapeutics Inc | 6.4 | High |
| 402 | Alembic Pharmaceuticals Ltd | 6.4 | High |
| 402 | Aspen Pharmacare Holdings Ltd | 6.4 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Capricor Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Capricor Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Capricor Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Capricor Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Capricor Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Capricor Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Capricor Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Capricor Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Capricor Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Capricor Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Capricor Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Capricor Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Capricor Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Capricor Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Capricor Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Capricor Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Capricor Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Capricor Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Capricor Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Capricor Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Capricor Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Capricor Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Capricor Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Capricor Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Capricor Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Capricor Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Capricor Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Capricor Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Capricor Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Capricor Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Capricor Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Capricor Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Capricor Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Capricor Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Capricor Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Capricor Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Capricor Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); and CAP-1002, which is in Phase II clinical trial for the treatment of cytokine storm associated with SARS-CoV-2. The company also develops CAP-2003 that is in pre-clinical development for the treatment of trauma related injuries and conditions; and two vaccine candidates, which are in development stage for the potential prevention of COVID-19. It collaborates with Lonza Houston, Inc. for the clinical manufacturing of CAP-1002, its cell therapy candidate for the treatment of DMD and other indications. The company was founded in 2005 and is headquartered in San Diego, California.